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Abstract
Background: Most developed countries have increasing numbers of community dwelling older people with both multi-
morbidity and sensory impairment that includes visual, hearing or dual impairment. Older people with sensory impairment
are more likely to have chronic health conditions and to be in receipt of polypharmacy (>4 medicines). It is important to
understand their experience of pharmaceutical care provision to facilitate a safe, appropriate and person centred approach.
Aim: this study explored the pharmaceutical care experiences and perspectives of older people with sensory impairment
receiving polypharmacy.
Design and setting: exploratory qualitative study with semi-structured telephone or face-to-face interviews with commu-
nity dwelling older adults with sensory impairment receiving polypharmacy in Scotland in 2016.
Methods: in total, 23 interviews were conducted with older people from seven of the 14 Scottish Health Board areas.
Subjects: over half the participants (n = 12) had dual sensory impairment, six had visual impairment and ﬁve had hearing
impairment.
Results: three overarching themes were identiﬁed reﬂecting different stages of participants’ pharmaceutical care journey:
ordering and collection of prescriptions; medicine storage; and administration. At each stage of their journey, participants
identiﬁed barriers and facilitators associated with their pharmaceutical care.
Conclusions: this is the ﬁrst comprehensive, in-depth exploration of the pharmaceutical care journey needs of older people
with sensory impairment. As the number of community dwelling older people with sensory impairment and polypharmacy
increases there is a requirement to identify challenges experienced by this population and offer solutions for safe and effect-
ive pharmaceutical care provision.
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Key points
• Older people with sensory impairment receiving polypharmacy are at increased risk of experiencing adverse drug events.
• This population face challenges along their pharmaceutical care journey including ordering, storing and administering
medicines.
• A system-wide approach is needed to provide continuous and safe integrated pharmaceutical care to this population.
Background
Globally, more people are living longer with multimorbidity
[1] requiring complex treatment regimens and coordinated
pharmaceutical care [2]. In Scotland, projections show a
25% increase in people >75 years with complex health and
social care needs [3]. Impairments in vision, hearing, mobil-
ity and cognition become more prevalent with increasing
age [4]. Sensory impairment (SI) in older adults include vis-
ual, hearing or dual impairments with signiﬁcant impact on
both function and quality of life [5, 6]. Visual Impairment
(VI) is associated with falls, cognitive function, depression
and mortality [5]. Impairment of either vision or hearing
poses challenges for people to communicate and navigate
their physical and social environments. The prevalence of
Dual Sensory Impairment (DSI) requires more comprehen-
sive environmental adaptations and assistance than required
for hearing or visual impairment alone [7]. Older people
with VI/HI/DSI are all more likely to report higher rates
of comorbid conditions than older people without SI [6].
These complexities pose particular challenges in the pro-
vision of effective, accessible and timely pharmaceutical
care, especially when it involves polypharmacy or complex
medication regimens [6]. Polypharmacy is the prescribing of
multiple items to one individual [8] and is often categorised
as using four or more medicines [9]. Polypharmacy is not
limited to prescription drugs and oral medications but also
includes injections, suppositories, and creams along with
over-the-counter medication and alternative therapies.
Pharmaceutical care is a philosophy of practice where the
patient is the primary beneﬁciary of the pharmacist’s or phar-
macy personnel’s actions. Pharmaceutical care focuses on the
provision of drug therapy with the goal of achieving thera-
peutic outcomes for patients’ health and quality of life [10].
In Scotland, 89% of older adults take one or more pre-
scribed medications [11]. Problematic polypharmacy arises
as a result of adverse drug interactions, inappropriate moni-
toring and patient non-adherence. Multimorbidity and poly-
pharmacy increase the risk of Adverse Drug Events
(ADEs), with reported prevalence of adverse drug reactions
in community dwelling older people being as high as 78%
[12]. One in ﬁve older adults >65 years are at risk of
inappropriate and potentially harmful prescription medica-
tion use [13]. It is estimated that ADEs annually cause
nearly 100,000 emergency hospitalisations of adults > 65
years in the USA [14]. Errors can occur at different stages
of medication use when weak medication management sys-
tems and/or human factors such as fatigue and poor
environmental conditions affect prescribing, transcribing,
dispensing, administration and monitoring practices [15].
These factors may be magniﬁed for people with SI. In one
study, compared to peers without VI, older people with VI
were more likely to need help with their prescribed medica-
tion, had difﬁculty reading information, distinguishing
between medications and opening packaging [16]. In
another study, participants with HI had the lowest medica-
tion knowledge scores compared to those without HI [17].
Challenges reported by patients with VI include, difﬁcul-
ties identifying medicines, recognising dosages and identify-
ing expiry dates [18], reading labels and lack of awareness
of appropriate storage requirements [19]. A study on the
pharmaceutical care needs of older people with SI, found
that both patients and pharmacy personnel identiﬁed a wide
range of factors that inﬂuenced access and provision of
pharmaceutical care across all stages of the pharmaceutical
care journey i.e. from the ordering or supply of medicines
to their storage and administration [20]. While there is a
growing body of literature that focuses on medicines man-
agement of older people generally, a recent scoping review
revealed a paucity of research in relation to older people
with SI [21]. There is recognition that person-centred
pharmaceutical care may be successful in ensuring that old-
er people are receiving the right medicines [2, 22]; yet we
identiﬁed no studies that explored the perspectives of older
people with SI receiving polypharmacy and their experi-
ences with community-based pharmaceutical care.
The data presented here are part of a wider programme
of work that explored pharmaceutical care of older people
with SI receiving polypharmacy in Scotland. Findings from
other elements of the study are reported elsewhere [20, 23].
The aim of the study reported here was to explore speciﬁc-
ally the experiences and perspectives of older adults with SI
on their pharmaceutical care journey.
Method
This exploratory qualitative study included semi-structured
telephone or face-to-face interviews (depending on partici-
pant’s preference) undertaken with community dwelling old-
er adults with SI receiving polypharmacy (hereafter referred
to as older people) in Scotland in 2016.
Sampling and recruitment
Older people were identiﬁed using purposive sampling [24]
to reﬂect gender, age, geographic location, living alone or
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with others, and those managing their medicines on their
own or with caregiver assistance. Eligibility for participation
were individuals aged >65 who had a SI (visual, hearing or
dual impairment), regularly used ≥4 medicines and were
community-dwelling in Scotland. Participants were mostly
recruited through emails sent from relevant organisations
(Forth Valley Sensory Centre, Perth Macular Society, Action
on Hearing Loss and North East Sensory Services) and a
newsletter advertisement by Sight Action (a Scottish charity
supporting people with VI). Interested participants either
contacted the researcher or gave consent for the researcher
to contact them. A member of the research team (KK) was
also invited to explain the study to service users attending a
hearing aid clinic through which some participants were
recruited.
A study information pack compliant with accessibility
requirements for people with low vision [25] was forwarded
to all participants who expressed an interest and participants
were required to provide consent. Access to British Sign
Language (BSL) interpreters for people with HI was antici-
pated, but was not requested by any research participant.
Ethics and accessibility and recruitment procedure
approval
Ethical review and approval were received from the
University of Dundee Research Ethics Committee (January
2016: Ethics Review reference number 15187).
Data collection
A semi-structured interview guide (Box 1) developed for
the interviews was peer reviewed by the Project Advisory
Group that comprised of individuals with SI, representa-
tives from sensory disability organisations and the research
team. Interviews sought to explore how older people mana-
ged their medicines including barriers and facilitators in the
pharmaceutical care journey, especially in relation to obtain-
ing medicines, managing complex medicine regimens, and
perceived safety risks. Two pilot interviews were conducted
(one each with a person with HI and a person with VI) and
no further changes were required in relation to interview
guide content or mode of administration. Participants self-
disclosed their sensory impairment, heath status and their
medicine regime at interview. All interviews were conducted
by KK until data saturation [26] was deemed to have been
reached i.e. no new information relating to the topics of
interest were obtained.
Data management and analysis
Interviews were digitally recorded, transcribed verbatim and
converted to anonymous word ﬁles. Transcripts were con-
tent coded and analysed thematically using a coding frame-
work that was developed inductively from the data and
followed guidelines for qualitative thematic analysis [27].
Two researchers [NA, AT] independently coded ﬁve inter-
views to assess consistency with coding. Variations in
coding were reviewed and agreed [27] and the coding
framework was further reﬁned and ﬁnalised by NA, AT,
MW, LM and AS. All interviews were then coded based on
this framework [NA] and veriﬁed by AT. Data were mana-
ged using NVivo (version 10).
Results
In total, 23 interviews were conducted with older people
recruited from seven Scottish Health Board areas. Twelve
participants had dual SI, 6 had VI and 5 had HI.
Participant characteristics are detailed in Table 1. Interviews
lasted on average for 28 ± 11 minutes.
Three overarching themes were identiﬁed that reﬂected
different stages of participants’ pharmaceutical care journey,
including facilitators and barriers for ordering and collec-
tion of prescriptions; medicine storage; and administration
(Figure 1).
Box 1: Semi structured interview guide
1. Tell me about your sensory impairment. How does
it affect you?
2. Tell me about how you manage your medicines.
3. Do you have any difﬁculties or problems managing
your medicines?
4. [If relevant] What support, if any, would you like to
help you manage your medicines?
5. How do you obtain your medicines?
6. What, if anything, do you use a community phar-
macy for?
7. Talk me through a recent time that you have used*
a community pharmacy.
8. Are you aware of how your community pharmacists
could help you manage your medicines?
9. What role, it any, does your community pharma-
cist/community pharmacy play in helping you man-
age your medicines?
10. What support, if any, would like to receive from
your pharmacist to help you manage your
medicines?
11. Is there anything that your pharmacist/community
pharmacy does that makes it easier or harder for
you to manage your medicines?
12. How often do you use a community pharmacy? Do
you use the same one?
13. Is your community pharmacy aware of your sensory
impairment [If yes – how did this happen? If no,
why is that?]
14. What, if anything, makes it difﬁcult for you to use a
community pharmacy?
15. What, if anything, helps you to use a community
pharmacy?
16. Is there anything else relating to the topics that we
have covered today that you would like to tell me?
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Ordering and collecting prescriptions
Stage one of the pharmaceutical care journey describes par-
ticipants’ experiences with ordering and collecting their pre-
scriptions from community pharmacies. The majority of
participants regularly re-ordered their own prescriptions,
usually contacting their General Practitioner (GP) and col-
lected their prescription from the community pharmacist.
Most participants telephoned for their repeat prescriptions,
with some people using accessible technology, for example,
large display screens or voice recognition.
‘And now that you can order everything online which is very han-
dy…I just go into patient access and it tells me when I last ordered
it and all the information is on it which is very good… I mean I’ve
got a 32 inch screen I use for my computer.’ Participant 5, DSI
‘I send an email to the [surgery]…and tell them what I want
because I have got this wonderful thing on the computer that allows
me to speak to it; I don’t need to type.’ Participant 8, VI
Some participants ordered their prescriptions online with
family member support.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Participants’ characteristics
Participant
number
Age
(years)
Sensory impairment
(SI)
Living
arrangement
Number of sensory aids
used
Number of co-
morbidities
Number of medicines/
day
1 75 Dual Lives with family 4 5 5
2 86 Dual Lives alone 3 9 11
3 89 Visual Lives alone 2 4 7
4 68 Visual Lives with spouse 2 6 11
5 75 Dual Lives alone 4 4 6
6 78 Dual Lives with spouse 3 6 9
7 76 Visual Lives with spouse 1 3 6
8 89 Visual Lives alone 3 3 5
9 86 Dual Lives with spouse 2 3 7
10 88 Dual Lives alone 4 4 14
11 76 Dual Lives with spouse 2 4 4
12 70 Visual Lives alone 2 1 6
13 78 Hearing Lives with spouse 2 6 11
14 87 Hearing Lives alone 1 9 11
15 74 Hearing Lives with spouse 2 5 14
16 89 Dual Lives alone 1 7 5
17 91 Dual Lives alone 2 5 9
18 95 Dual Lives alone 2 5 4
19 80 Dual Lives alone 2 3 4
20 83 Visual Lives alone 1 3 5
21 81 Hearing Lives with spouse 1 4 8
22 73 Dual Lives alone 2 2 20
23 67 Hearing Lives alone 1 5 8
Figure 1. Stages of the pharmaceutical care journey of older people with sensory impairment.
A. Smith et al.
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‘My daughter, just two nights ago, had got me logged onto the internet
method of trying to access repeat prescriptions.’ Participant 1, DSI
The processes for ordering medicines were inconsistent;
one participant described the lack of support with informa-
tion to reorder their prescriptions.
‘They don’t have any sort of leaﬂet which I could have brought home
and got my husband to read or I could have put it on the CCTV
[type of magniﬁer] or I would probably have managed with a magni-
ﬁer. So I was told nothing about how to reorder.’ Participant 7, VI
Participants with a HI reported communication difﬁculties
with ordering their prescriptions over the telephone.
‘It is difﬁcult on the phone, you think you hear, they tell you to
put it [hearing aid] behind your ear but there is this terrible
noise that people hear at the other end.’ Participant 11, DSI
Participants with HI reported that they did not always hear
complete medicine instructions and instead predicted what
had been said. This barrier was ampliﬁed when conversa-
tions were conducted on the telephone. Having face-to-face
direct conversation, speaking slowly and clearly helped with
the quality of communication. Some participants with hearing
aids also used lip reading techniques to aid comprehension;
however, not all HI participants were adept at lip reading.
‘The brain has processed what she said, even if you hadn’t heard
all of it…You know what they’re going to ask, even if you
didn’t hear it particularly well.’ Participant 15, HI
Participants collected their medicines from the community phar-
macy either in person, with the assistance of a friend or family
member or the prescription was delivered to their home by a
delivery driver. Some people with VI reported that the layout of
pharmacies with narrow aisles could be difﬁcult to navigate and
recounted bumping into shelves and other customers. Others
reported more conﬁdence in negotiating the pharmacy environ-
ment particularly when the pharmacy counter was situated near
the entrance. Familiarity with the layout was advantageous and
this was also helpful for participants with guide dogs.
‘My guide dog and I would just walk along up to the pharmacy
and [dog’s name] would recognise where the door is and I know
approximately when I’m walking with him where the pharmacy
is.’ Participant 4, SI
The home delivery service was described as helpful despite
the fact that there was no direct contact with their pharma-
cist to discuss any problems. Participants who used the
home delivery service were overwhelmingly positive,
describing it as ‘very good’, ‘excellent’ and ‘tremendous’ and one
participant changed their pharmaceutical care provision to a
pharmacy that provided a delivery service.
‘Well I think the biggest help is getting them delivered. I used to
have to get somebody to go but then [pharmacy name] deliver
them so he comes every week with them.’ Participant 10, DSI.
The home delivery service was not without its own chal-
lenges. Participants reported difﬁculties accessing the
delivery service due to long waiting lists, partial delivery of
prescriptions, delivery to the wrong address and lack of a
ﬁxed schedule for delivery.
Medicine storage
Once participants received their prescriptions, they used
various strategies to sort and store their medicines. In gen-
eral, participants had developed their own bespoke storage
systems and adhered to these systems as a matter of rou-
tine. It was not unusual for medicines to be dispensed out
of their original packaging into participants’ own containers
—this included dispensing from standard medicine contain-
ers and from blister dispensing packs.
‘Well I keep them in a container, in the same place because if I
move things, I lose them. I just have the tablet and the capsule,
that’s all I have.’ Participant 17, DSI
‘Blister packs…I have given up on entirely and I just worked
out my own system in getting them out in 7’s… I’ve worked out
a system of doing them so I know where I am. It’s not the sys-
tem that they write, partly because you can’t read it and partly
because they’re all different.’ Participant 20, VI
One participant systematically sorted and stored medicines
in different places around the house according to their
administration time.
‘Very carefully. I put them in certain places so that I know
I’ve taken that, I’ve taken that, that kind of thing.’
Participant 22, DSI
Many of the participants used dosette boxes (multiple dis-
pensing compartments divided by time and date) to sort
and store their medicines and opinions about these varied,
some found the devices helpful and others described difﬁ-
culties with using them. Participants with VI often sought
assistance to ﬁll the dosette boxes.
‘If it’s simply a case of these little things with seven little
boxes I can get somebody to do my own pills and put them in
one of these…The girl who comes in and cleans for me.’
Participant 3, VI
‘I’ve got dosette boxes, I tried them once going on holiday because
I was going for two weeks and honestly what a disaster it
was… because of my vision…Just chaotic.’ Participant 7, VI
Blister packets [multi-compartment compliance aids] that
were pre-ﬁlled by pharmacists were used by a number of
participants who described them as ‘helpful’ for organising
their medicines. Some difﬁculties were also reported with
blister packs including challenges with the dexterity required
for ‘popping’ the tablet out of the foil bubble and with the
colour and writing on the packets. Additionally, participants
on warfarin found this method of storage unhelpful due to
frequent dosing changes.
‘It doesn’t always come out and if it falls out or it bursts out
and it bounces off and it disappears….why don’t you just have
A qualitative exploration of community dwelling older adults receiving polypharmacy
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a little peel you can take off… I think a better designed blister
pack that’s easier to access.’ Participant 5, DSI.
‘When you look at it ….usually you get a lot of blue printed on
white backgrounds which for me is just a killer but you learn
after that.’ Participant 5, DSI
‘I’ve got one that you can’t read the wordings that they’ve got on
the pack, when you open your big cardboard pack and you take
out your metal glittery pack, I can’t read the lettering on that,
unless again, I use these very strong lenses.’ Participant 20, VI
One participant had indicated that waiting lists existed for
blister packs, while another who had revealed their SI to the
community pharmacy was prioritised for the blister pack.
‘So when I went out I went to see [name] and I explained to
them and they said ‘no problem’. ‘Sight loss, we’ve got a waiting
list but we’ll enter you onto the list and we’ll get you started
next week’. Participant 5, DSI
Medicine administration
In relation to medicine administration, most of the data
reported here was from participants with VI. They
described reliance on the texture and the colours of the
boxes or the tablets. However, this was not always the case.
Participants reported that most tablets were ‘round; white,
small and hard to distinguish’.
‘I use anything. I use the shape sometimes. Some are long length
wise, sometimes they’re pointed at each end…I sort of become
friends with them.’ Participant 18, DSI
‘I can hold them very close up to my eye, by which I mean about
an inch away, and then I can identify the individual pills. But
there is a tendency, I mean, a pink one for heart, for blood pres-
sure and it becomes invisible if I put it on the palm of my hand.
I know it sounds silly. It’s vaguely ﬂesh coloured and it literally
disappears amongst the white pills’ Participant 20, VI
Changing medicine brands was detrimental because it also
meant changing the shapes and colours that people with VI
used to distinguish their medicines and hence posed a risk
to safe administration.
‘I was complaining to my wife about feeling really light headed
and that sometimes can be symptomatic of a hypo coming on…
‘Are you sure you’ve been taking your medication right?’ she
said and I said, ‘I don’t know… so I got it out and bingo they
had reintroduced the 4 mg tablets and I was taking 8 (4 mg)
tablets a day instead of 8 (2 mg) tablets so my blood pressure
just went right down.’ Participant 5, DSI
There were reported instances of pharmacists being pro-
active and supportive in notifying the participant when
these changes happened.
‘Well he’s excellent actually. If my medication has changed or if
anything is different about it, he will phone and make sure I
know what I am doing before I get it.’ Participant 3, VI
Participants reported that they depended on their family/
carers to ensure safety with their medicines administration,
and in the following extract helped to mitigate human
error.
I’ve actually had the wrong medicine supplied to me…and I was
just about to take some tablets and [wife name] says to me
‘what’s that you’ve got now?’ and I said ‘it’s my medicine’ that I
was put on… and she said ‘that’s not what you’re on’ and we
looked at the packages. It wasn’t even for me it was for a guy in
the village three miles down the road.’ Participant 4, VI
Some formulations (e.g. eye ointments, rectal suppositories,
glucose test strips) were reported to be more difﬁcult to
manage by older people with VI. Problems with opening
sealed bottles were exaggerated by ﬁne tremors.
Forgetfulness alongside their SI also ampliﬁed safety
concerns.
‘When you’re blind you cannot really do ointments. Not into
your eyes anyway.’ Participant 4, VI
‘Once I drop them and then I was in trouble because I only had
to judge the size of the tablets and even with the magniﬁer it
was difﬁcult to tell.’ Participant 16, DSI
‘You know, over time you get used to knowing… you’ve got to
have it in your head. If you were in any way going down the
path of forgetfulness or dementia or something, it would become
impossible because you wouldn’t know which one you were look-
ing at.’ Participant 20, VI
Discussion
To our knowledge, this is the ﬁrst in-depth exploration of
the pharmaceutical care needs of community dwelling older
people with SI and it highlighted the challenges encountered
in their pharmaceutical care journey. A recently developed
scale to assess the functional characteristics of older com-
munity dwelling people with pharmaceutical care needs
does not speciﬁcally examine sensory changes [28].
Moreover, most research has focused on the pharmaceut-
ical care of older people in residential care and nursing
homes or examined the prescribing challenges for general
practitioners and pharmacists. Some of the experiences
described by participants in this study will be encountered
by older people in general, however in many instances the
issues identiﬁed are intensiﬁed by the presence of the SI
impacting on all aspects of the pharmaceutical care journey.
As health services change from face-to-face to internet-
based services, for example, for advice and ordering medi-
cines, this creates both opportunities and challenges for old-
er people with SI. Many older people may be reluctant to
fully embrace the internet for services [29], or as in this
study, require additional help from their carers to do so.
Some older adults with SI might still prefer the personal,
face-to-face contact with their pharmacist and ﬁndings
from the study highlighted the signiﬁcance of good com-
munication between participants and community
A. Smith et al.
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pharmacist personnel. Furthermore, disclosure of SI can
facilitate improved pharmaceutical care [21]. When commu-
nication is inadequate, for example, if advice is not heard
properly or cannot be read, the potential for drug error
increases. People with HI felt that they often misunderstood
the information given about their medications by pharma-
cists in its entirety, but often gave the impression that they
understood the pharmacists’ instructions [29]. Whilst phar-
macists believed that the provision of written information is
a sufﬁcient method of communication [23], it might result
in important information being omitted due to time pres-
sures and it also does not ensure that the patient under-
stands or can read the information [18].
While some participants reported challenges with home
medicines delivery in terms of reliability and delays, most
were positive about the service. However, delivery systems
may be operated independent of the community pharmacy
and drivers who deliver the medication are not trained in
pharmaceutical care which may pose safety concerns [30].
Whilst having assistance from family members or carers
may help, this support is not always guaranteed and rein-
forces the need for safe delivery services.
People with SI reported creative strategies to manage
their medicines. Participants had developed bespoke sys-
tems for storing and managing medicines in their home.
Assistive aids such as blister packs and dosette boxes while
helping with the organisation of medication may not be
helpful for all older people, especially when limited dexterity
is compounded by SI. Similar difﬁculties with medicine for-
mulation, packaging and instructions have been reported
with older people more generally [22]. Evidence also con-
ﬁrms that people with VI manage their medicines solely by
memory to distinguish between medicines and dosages
[13, 19]. Our data however showed how this approach may
be compromised through the frequent changes in size and
shape of prescription medication and alterations in the per-
son’s memory and cognition.
Recommendations
Our ﬁndings show that fragmented approaches that only
seek to address one element of the complex medicine man-
agement challenges experienced by older people with sen-
sory impairment receiving polypharmacy are inadequate.
The reported experiences point to the need of system-
focused solutions to provide continuous and integrated,
person-centred support for this population in community
settings. We need to improve the communication and data-
sharing interface between general practice, community phar-
macy, and carers.
Pharmaceutical care, just like any other form of support
or assistance needed, could be further improved by involv-
ing all stakeholders in designing care pathways for ordering
and managing medicines. Older adults placed at the centre
of this effort can co-design acceptable, user-friendly and
accessible solutions in collaboration with health care practi-
tioners and assistive device manufactures.
Limitations
The study generated rich data and a range of perspectives
by interviewing people with SI. Study limitations include its
relatively small sample size and focus in a country where
access to healthcare, including medicines, is provided at no
direct ﬁnancial cost to the recipient. Findings may be trans-
ferable to individuals in similar circumstances. A detailed
subgroup analysis in relation to speciﬁc experiences of peo-
ple with vision vs hearing vs dual SI was not undertaken as
a larger sample would be required to comprehensively cap-
ture people’s experiences in each of the subgroups. In
future, obtaining the perspectives of general practitioners
and carers in addition to community pharmacists and ser-
vice users would be desirable.
Conclusions
As the number of older people with SI and polypharmacy
increases, adaptations are needed for the provision of
pharmaceutical care to this population. Greater service user
involvement in the design of services is desirable. A
bespoke initiative to work collaboratively with home-
dwelling older adults, carers, general practitioners and com-
munity pharmacists in urban and rural communities in co-
designing support systems could complement this work.
Clearly, a system-wide approach is needed to address the
complex requirements and to provide continuous and inte-
grated pharmaceutical care of this population as their needs
and assistive requirements change over time.
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